Diagnostic Approach and Management of Pleural Fluid Carcinoma

Initial Diagnostic Steps

• The American College of Chest Physicians recommends starting with thoracentesis with pleural fluid cytology, followed by image-guided pleural biopsy if the initial thoracentesis is non-diagnostic and CT shows pleural thickening or nodularity 1, 2
• For cytological analysis, 25-50 mL of pleural fluid should be submitted, with smaller volumes sent if necessary, but with awareness of reduced sensitivity 3
• Pleural fluid cytology has a mean sensitivity of approximately 72% (range 49-91%) when at least two specimens are submitted, with a second specimen yielding diagnosis in 25-28% of cases if the first is negative 1
• The following tests should be ordered for suspected malignancy:

Imaging and Biopsy

• Contrast CT scan of the chest helps differentiate between benign and malignant pleural diseases, with features suggestive of malignancy including circumferential pleural thickening, nodular pleural thickening, parietal pleural thickening >1 cm, and mediastinal pleural involvement 1
• Percutaneous image-guided cutting needle biopsy is superior to blind Abrams needle biopsy, with a sensitivity of 84% and a negative predictive value of 75-80% 1
• The pneumothorax rate following image-guided pleural biopsy is approximately 5% 1

Sampling and Volume Considerations

• Submitting more than 50 mL of pleural fluid does not increase diagnostic yield, and sample preparation affects yield, with both cell block and smear recommended 1
• Cytology sensitivity varies by tumor type, with the highest sensitivity for adenocarcinoma 1
• Thoracentesis is a procedure used to remove fluid from the pleural space, with volume administration titrated to improvement of blood pressure being a reasonable first approach, according to the American Heart Association 5

Pre-Procedure Evaluation and Risks

• Patients should be evaluated for risk factors before thoracentesis, including duration of effusion, cardiopulmonary status, coagulation parameters, and mechanical ventilation, to reduce complications 5
• Risk factors for re-expansion pulmonary edema (REPO) include:

• Patients with coagulopathy are at increased risk of bleeding complications, and those on mechanical ventilation are at higher risk of pneumothorax, and skin infection at the insertion site can introduce infection, as general principles supported by medical guidelines 7

Procedure Techniques and Safety

• Monitoring pleural pressures during large-volume thoracentesis can help prevent excessive negative pressure development, and terminate the procedure if end-expiratory pleural pressure drops below -20 cm H₂O, patient develops chest discomfort, or signs of hemodynamic instability appear, as recommended by the American Thoracic Society 5
• Ultrasound guidance improves safety and reduces complications during thoracentesis by allowing better visualization of fluid location and volume, and helping avoid inadvertent organ puncture, which is a general recommendation in the field of thoracentesis, and is supported by the evidence provided in the article, although the specific citation is not provided 5
• Ultrasound should be used to guide thoracentesis, especially for loculated effusions, with a success rate of 97% for loculated effusions, as recommended by the American Thoracic Society 7, 8, 9

Management of Pleural Effusions

• Initial drainage should be limited to 1-1.5 liters per session to prevent re-expansion pulmonary edema, as recommended by the British Thoracic Society 8, 6
• Limiting initial drainage to 1-1.5 liters helps prevent significant hemodynamic changes, and monitoring pleural pressure during large-volume drainage adds safety, as recommended by the American Thoracic Society 5
• The American Thoracic Society recommends ultrasound-guided thoracentesis with initial drainage limited to 1-1.5 liters to prevent re-expansion pulmonary edema, followed by consideration of definitive management with either indwelling pleural catheter or chemical pleurodesis in patients with asymmetric pulmonary edema and large right-sided pleural effusion 6
• Optimize fluid status by adjusting diuretic dosing and consider increasing to twice daily or higher dose if needed, and address underlying causes by reviewing cardiac medications and ensuring optimal dosing for heart failure management 6
• Monitor closely for complications, especially re-expansion pulmonary edema, and consider temporary discontinuation of anticoagulant medication before invasive procedures 4

Definitive Management Options

• Talc slurry pleurodesis can be performed using small-bore (10-14F) intercostal tubes, with 4-5g talc instilled in 50ml normal saline, and the tube clamped for 1 hour after instillation, according to the American Journal of Respiratory and Critical Care Medicine 4
• Talc poudrage, performed via thoracoscopy, has similar efficacy to talc slurry, as reported by the American Journal of Respiratory and Critical Care Medicine 7
• Talc pleurodesis (either poudrage or slurry) can be used for patients with expandable lung, as recommended by the American Thoracic Society and the European Respiratory Society 7, 10
• IPC is equally effective as chemical pleurodesis for symptom control, allows outpatient management, and is suitable for patients who may need repeated drainage, according to the American Journal of Respiratory and Critical Care Medicine 7
• IPC is preferred over chemical pleurodesis in patients with non-expandable lung, as reported by the American Journal of Respiratory and Critical Care Medicine and Thorax 7, 3
• For malignant pleural effusions with expandable lung, either indwelling pleural catheter or chemical pleurodesis can be used, according to the American Thoracic Society 7
• For non-expandable lung or failed pleurodesis, indwelling pleural catheters are preferred 7
• Pleuroperitoneal shunt may be considered in appropriate cases, as reported by the American Journal of Respiratory and Critical Care Medicine 4

Post-Procedure Care and Complications

• Thoracentesis increases total lung capacity (TLC) by approximately one-third the volume of fluid removed, and forced vital capacity (FVC) increases by one-half the increase in TLC, according to the American Thoracic Society 4
• The effect on arterial oxygen levels (PaO2) is variable and can increase, remain the same, or decrease after thoracentesis, as reported by the American Thoracic Society 4
• A respiratory physician or thoracic surgeon should be involved in the care of all patients requiring chest tube drainage for pleural infection, as recommended by the British Thoracic Society 11
• For patients with non-resolving pleural infections despite chest tube drainage, consider intrapleural fibrinolytics (TPA plus DNase), according to the British Thoracic Society 3
• Surgical intervention (VATS or thoracotomy) should be considered when medical management fails, as recommended by the British Thoracic Society 3